- Home
- GSK vs BTI Comparison
GSK vs BTI Comparison
Compare GSK & BTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GSK | BTI |
|---|---|---|
| Founded | 1715 | 1902 |
| Country | United Kingdom | United Kingdom |
| Employees | 66841 | 50290 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.7B | 134.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GSK | BTI |
|---|---|---|
| Price | $52.50 | $62.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | N/A | ★ $62.00 |
| AVG Volume (30 Days) | 3.9M | ★ 4.0M |
| Earning Date | 04-29-2026 | 02-12-2026 |
| Dividend Yield | 3.40% | ★ 5.51% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.99 | $3.72 |
| Revenue Next Year | $4.19 | $3.56 |
| P/E Ratio | $32.75 | ★ $12.53 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.45 | $46.38 |
| 52 Week High | $61.70 | $67.30 |
Technical Indicators
Market Signals| Indicator | GSK | BTI |
|---|---|---|
| Relative Strength Index (RSI) | 53.30 | 56.34 |
| Support Level | $51.55 | $57.74 |
| Resistance Level | $53.45 | $62.59 |
| Average True Range (ATR) | 0.91 | 0.98 |
| MACD | 0.11 | 0.18 |
| Stochastic Oscillator | 58.87 | 86.67 |
Price Performance
Historical ComparisonAbout GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About BTI British American Tobacco Industries p.l.c. ADR
The third-largest tobacco company by volume, British American Tobacco sold 465 billion cigarettes in 2025. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the US. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 22.9% stake in ITC limited, the largest Indian cigarette company.